Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-289-7 | CAS number: 520-27-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Genetic toxicity in vitro. Weight of evidence: Four Ames tests for the analogue substance neohesperidin dihydrochalcone, all of them similar to OECD 471 (no GLP), were all negative. Based on the available information for the read-across approach, the target substance is deemed to be non-mutagenic.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1987.
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- only 4 strains tested.
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
The laboratories were supplied with the chemicals, which were coded by the NTP chemical repository (Radian Corp., Austin, TX), along with information on the physical characteristics of the chemicals, their solubility in different solvents, and safety and decontamination information. Supplier: Res.Organic/inorganic.
- Name of test material (as cited in study report): neohesperidin dihydrochalcone
- Molecular formula (if other than submission substance): C28H36O15
- Molecular weight (if other than submission substance): 612.5764
- Smiles notation (if other than submission subs.): CC1C(O)C(O)C(O)C(OC2C(O)C(O)C(CO)OC2Oc2cc(O)c(C(=O)CCc3ccc(OC)c(O)c3)c(O)c2)O1
- InChl (if other than submission subs.): InChI=1/C28H36O15/c1-11-21(34)23(36)25(38)27(40-11)43-26-24(37)22(35)19(10-29)42-28(26)41-13-8-16(32)20(17(33)9-13)14(30)5-3-12-4-6-18(39-2)15(31)7-12/h4,6-9,11,19,21-29,31-38H,3,5,10H2,1-2H3
- Structural formula attached as image file (if other than submission substance): see Fig. in attached report. - Target gene:
- histidine requiring gene
- Species / strain / cell type:
- S. typhimurium TA 1535
- Details on mammalian cell type (if applicable):
- All strains were obtained from Dr. Bruce Ames (University of California, Berkeley) and were stored as recommended [Maron and Ames, 19831. Prior to their use for mutagenicity assays, all cultures were grown overnight with shaking at 37°C in Oxoid broth, and their phenotypes were analyzed.
- Additional strain / cell type characteristics:
- not specified
- Species / strain / cell type:
- S. typhimurium TA 98
- Details on mammalian cell type (if applicable):
- All strains were obtained from Dr. Bruce Ames (University of California, Berkeley) and were stored as recommended [Maron and Ames, 19831. Prior to their use for mutagenicity assays, all cultures were grown overnight with shaking at 37°C in Oxoid broth, and their phenotypes were analyzed.
- Additional strain / cell type characteristics:
- not specified
- Species / strain / cell type:
- S. typhimurium TA 100
- Details on mammalian cell type (if applicable):
- All strains were obtained from Dr. Bruce Ames (University of California, Berkeley) and were stored as recommended [Maron and Ames, 19831. Prior to their use for mutagenicity assays, all cultures were grown overnight with shaking at 37°C in Oxoid broth, and their phenotypes were analyzed.
- Additional strain / cell type characteristics:
- not specified
- Species / strain / cell type:
- S. typhimurium TA 97
- Details on mammalian cell type (if applicable):
- All strains were obtained from Dr. Bruce Ames (University of California, Berkeley) and were stored as recommended [Maron and Ames, 19831. Prior to their use for mutagenicity assays, all cultures were grown overnight with shaking at 37°C in Oxoid broth, and their phenotypes were analyzed.
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S-9 mix.
- Test concentrations with justification for top dose:
- 100, 333, 1000, 3333 and 10000ug/plate.
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO.
- Justification for choice of solvent/vehicle: The solvent of choice was distilled water, followed by dimethyl sulfoxide, 95% ethanol, and acetone. The laboratory made an independent assessment of the solvent to be used. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- sodium azide
- other: 2-aminoanthracene, 4-nitro-o-phenylenediamine
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: preincubation. The preincubation assay was performed as described previously [Haworth et al, 1983]: The test chemical, Salmonella culture, and S-9 mix or buffer were incubated at 37ºC, without shaking, for 20 min. The top agar was added, and the contents of the tubes were mixed and poured onto the surface of petri dishes that contained Vogel-Bonner medium [Vogel and Bonner, 1956 (preparation: in 670ml distilled water are dissolved, successively: 10g MgSO4·7H2O, 100g citric acid·H2O, 500g anhydrous K2HPO4, 175g NaNH4HPO4·4H2O, the final volume being 1L; this solution is diluted 50x)]. The histidine-revertant (his+) colonies arising on these plates were counted following 2 days incubation at 37ºC. The plates were hand-counted when a precipitate was present; otherwise automatic colony counters were used.
- Cell density at seeding (if applicable):
DURATION
- Exposure duration: 48h
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth; other: A toxicity assay was performed to determine the appropriate dose range, by using TA100 or the system developed by Waleh (1982), see 'attached background material'.
- Any supplementary information relevant to cytotoxicity: Toxic concentrations were those at which a decrease in the number of his-f colonies was seen or at which there was a clearing in the density of the background lawn. Experiments were repeated at least 1 week following the initial trial.
- OTHER: The S-9 fractions of Aroclor 1254-induced, male Sprague-Dawley rat and male Syrian hamster livers were prepared as described previously [Haworth et al, 1983]. - Evaluation criteria:
- Data was evaluated as described by Haworth et al., 1983. An individual trial was judged mutagenic (+) if a dose-related increase over the corresponding solvent control was seen, and it was judged weakly mutagenic (+W) if a low-level dose response was seen. A trial was considered questionable (?) if a dose related increase was judged insufficiently high to justify a call of " + W," if only a single dose was elevated over the control, or if a non-dose-related increase was seen. A chemical was judged to be mutagenic (+), or weakly mutagenic (+W), if it produced a reproducible, dose-related increase in his+ revertants over the corresponding solvent controls in replicate trials. A chemical was considered to be questionable (?) if a reproducible increase of hist revertants did not meet the criteria for either a " + " or " + W," or if only single doses produced an increase in his+ revertants in repeat trials.
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 97
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- The test item was found to be non-mutagenic.
- Executive summary:
The ability of the test item to induce mutation was assessed by the bacterial reverse mutation test (Ames test), performed according to the method described by Haworth, similar to OECD 417. Four histidine dependent strains of Salmonella typhimurium (TA1535, TA97, TA98, TA100) were exposed to 0, 100, 333, 1000, 3333, and 10000 μg/plate of test item in the presence and absence of S9 metabolic activation (10 and 30% Aroclor 1254- induced hamster liver homogenate and rat liver homogenates), by the preincubation method. Under the experimental conditions used, the test item did not induce an increase in the number of revertants in any strain at any dose level, either with or without metabolic activation. Therefore, the test item was not mutagenic.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
See "attached justification". - Reason / purpose for cross-reference:
- read-across source
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 97
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- Based on the read-across approach, the target substance was found to be non-mutagenic.
- Executive summary:
The ability of the analogue substance neohesperidin dihydrochalcone to induce mutation was assessed by the bacterial reverse mutation test (Ames test), performed according to the method described by Haworth, similar to OECD 417. Four histidine dependent strains of Salmonella typhimurium (TA1535, TA97, TA98, TA100) were exposed to 0, 100, 333, 1000, 3333, and 10000 μg/plate of test item in the presence and absence of S9 metabolic activation (10 and 30% Aroclor 1254- induced hamster liver homogenate and rat liver homogenates), by the preincubation method. Under the experimental conditions used, the test item did not induce an increase in the number of revertants in any strain at any dose level, either with or without metabolic activation. Therefore, the test item was not mutagenic. Based on the read-across approach, the target substance was found to be non-mutagenic.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1978.
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- only 1 strain tested (TA98), only 3 doses tested.
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source: Compounds were prepared by selective methylation of quercetin or synthesized by established methods [10,19]. After repeated crystallization, the purity and identity of each compound was confirmed by elementary analysis and by UV or NMR spectra. The absence of quercetin was confirmed by thin-layer chromatography (TLC).
- Name of test material (as cited in study report): neohesperidin dihydrochalcone (No 36)
- Molecular formula (if other than submission substance): C28H36O15
- Molecular weight (if other than submission substance): 612.5764
- Smiles notation (if other than submission subs.): CC1C(O)C(O)C(O)C(OC2C(O)C(O)C(CO)OC2Oc2cc(O)c(C(=O)CCc3ccc(OC)c(O)c3)c(O)c2)O1
- InChl (if other than submission subs.): InChI=1/C28H36O15/c1-11-21(34)23(36)25(38)27(40-11)43-26-24(37)22(35)19(10-29)42-28(26)41-13-8-16(32)20(17(33)9-13)14(30)5-3-12-4-6-18(39-2)15(31)7-12/h4,6-9,11,19,21-29,31-38H,3,5,10H2,1-2H3
- Structural formula attached as image file (if other than submission substance): see Fig. in attached report. - Target gene:
- histidine requiring gene.
- Species / strain / cell type:
- S. typhimurium TA 98
- Details on mammalian cell type (if applicable):
- Presence of the R-factor plasmid was confirmed by cross-streaking strains TA98 and TA1538 on ampicillin and the presence of the rfa character by
crystal violet growth inhibition, as described by Ames et al. - Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix.
- Test concentrations with justification for top dose:
- 820, 1640 and 8197 nmol/plate.
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO.
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO.
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: quercetin, aflatoxin B1.
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation): The compound was dissolved in DMSO and added in a volume of 0.1mL after filter sterilization. An equivalent volume of solvent was added to the control plates. Each determination was carried out in duplicate.
NUMBER OF REPLICATIONS: 2 - Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- The test item is not mutagenic.
- Executive summary:
The ability of the test item to induce mutation was assessed by the bacterial reverse mutation test (Ames test), performed according to the method described by Ames, similar to OECD 417. An histidine dependent strain of Salmonella typhimurium (TA98) was exposed to 820, 1640, and 8197 μg/plate of test item in the presence and absence of S9 metabolic activation. Under the experimental conditions used, the test item did not induce an increase in the number of revertants at any dose level, either with or without metabolic activation. Therefore, the test item was not mutagenic.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
See "attached justification". - Reason / purpose for cross-reference:
- read-across source
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- Based on the read-across approach, the target substance is not mutagenic.
- Executive summary:
The ability of the analogue substance neohesperidin dihydrochalcone to induce mutation was assessed by the bacterial reverse mutation test (Ames test), performed according to the method described by Ames, similar to OECD 417. An histidine dependent strain of Salmonella typhimurium (TA98) was exposed to 820, 1640, and 8197 μg/plate of test item in the presence and absence of S9 metabolic activation. Under the experimental conditions used, the test item did not induce an increase in the number of revertants at any dose level, either with or without metabolic activation. Therefore, the analogue substance was found to be not mutagenic. Based on the read-across approach, the target substance is not mutagenic.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1979
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- only 4 strains tested.
- Principles of method if other than guideline:
- Study followed the Salmonella/mammalian microsome assay of Ames (see attached background material), with certain modifications of the routine-assay procedures to allow for nonmicrosomal enzymic activation of the flavonoid compounds (greater S9 fraction).
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source: Nutrilite Products, Buena Park, CA.
- Purity was assessed by TLC using polyamide plates (polyamide-6 UV2s4, 0.1 ram, Brinkmann) developed with chloroform : methanol : 2-butanone : acetone, 20:10:5:1 (v/v)
OTHER SPECIFICS:
- Name of test material (as cited in study report): neohesperidin dihydrochalcone
- Molecular formula (if other than submission substance): C28H36O15
- Molecular weight (if other than submission substance): 612.5764
- Smiles notation (if other than submission subs.): CC1C(O)C(O)C(O)C(OC2C(O)C(O)C(CO)OC
2Oc2cc(O)c(C(=O)CCc3ccc(OC)c(O)c3)c(O)c2)O1
- InChl (if other than submission subs.): InChI=1/C28H36O15/c1-11-21(34)23(36)25(38)27(40-11)43-26-
24(37)22(35)19(10-29)42-28(26)41-13-8-16(32)20(17(33)9-13)14(30)5-3-12-4-6-18(39-2)15(31)7-12/
h4,6-9,11,19,21-29,31-38H,3,5,10H2,1-2H3
- Structural formula attached as image file (if other than submission substance): see Fig. in attached
report. - Target gene:
- Histidine dependent gene.
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: Salmonella typhimurium strains TA1535, TA100, TA1537, TA1538, TA98 were obtained from Dr. Bruce N. Ames (University of California, Berkeley).
- Methods for maintenance in cell culture if applicable: Manipulation of these tester strains was carried out as recommended by Ames et al. [1]. Frozen permanents of each tester strain and the S-9 fractions (see below) were stored in sterile plastic vials under liquid nitrogen (Linde LR-30). Broth cultures of the tester strains were prepared in nutrient broth containing 0.5% NaCl. Five 25-ml Delong culture flasks, each containing 10 ml broth, were inoculated from frozen permanents of the respective tester strains and incubated 14-16h, 37ºC, 300 rpm in a New Brunswick G24 gyrotory incubator shaker. - Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 (Aroclor 1254 induced rat-liver microsome preparations)
- Test concentrations with justification for top dose:
- Various concentrations up to up to 200 μg/plate.
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Test agents were dissolved in dimethyl sulfoxide (DMSO) or sterile water.
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- ethylmethanesulphonate
- methylmethanesulfonate
- other: anthragallol, 2-anthramine
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:
- Preincubation: Up to 0.1 ml of a solution of the test agent in DMSO or water was combined with 0.1 ml of a culture of the tester strain and 0.5 ml of S9-mix in a sterile screwcap tube (16 X150 mm, Bellco) in an ice bath. The tube was then transferred to a water bath at 37ºC and incubated with occasional hand agitation for 30 min. Then 2.5 ml molten top agar (45ºC) were quickly added, mixed, and plated and incubated as usual. (method from Yahagi et al).
- Plate incorporation: Plates containing up to 200 μg test agent contained in a sterile 0.25-inch concentration disk applied to the top agar, were incubated 3 days at 35ºC.
- Test System: Qualitative plate tests (and in some cases, spot tests) were performed on the test agent. 1-2 days prior to the assay the bottom agar medium (Vogel - Bonner E plus 1.5% agar) was prepared, sterilized by autoclaving, tempered for 1 h at 50ºC, and 20 ml dispensed into Optilux (Falcon No. 1001) disposable plastic petri dishes with a Technomat automatic petri dish filler type 121 (Manostat, New York, NY). The top agar was prepared at the same time, autoclaved and tempered before 10 ml of sterile 0.5 mM L-histidine-0.5 mM d-biotin solutions are added per 100 ml agar. The complete top agar medium was dispensed (2.5 ml/tube) into new sterile disposable screw cap glass culture tubes (16 × 150 mm, Bellco Glass, Vineland, NJ). Immediately prior to pouring the top agar, 0.1 ml of the broth culture, 0.2 ml or less of the test solution, and, in the case of liver activation, 0.25 ml S9-mix were added. When present, 0.2 ml of cell-free extract was added.
DURATION
- Preincubation period: 30 min (preincubation method).
- Exposure duration: 72h
OTHER:
- Rat-liver homogenate fractions: Female Sprague Dawley rats (Simonsen Laboratories, Gilroy, CA) were maintained on Simonsen White laboratory diet. Removal of livers and subsequent preparation of the mammalian liver homogenate S9 fraction (9000 X g supernatant) and the S9-mix (0.2 ml S9 fraction per ml) was prepared as described by Ames. Aroclor induced S9 was prepared from animals injected i.p. 5 days prior to sacrifice with about 0.5 ml of a corn oil solution of Aroclor 1254 (400 mg/ml) to give a dose of 500 mg/kg bw. - Key result
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- his+ revertants per nmole: <0.01 revertants per nmol test agent.
his+ revertants per plate/ug: 0 (200) revertants per plate less background for a given quantity (ug) test agent. - Conclusions:
- No biologically significant increase in the number of revertants was noted in any strain at any dose level, either with or without metabolic activation. Therefore, the test item was not mutagenic.
- Executive summary:
The ability of the test item to induce mutation was assessed by the bacterial reverse mutation test (Ames test), performed according to the method described by Ames, similar to OECD 417. Four histidine dependent strains of Salmonella typhimurium (TA1535, TA1537, TA98, TA100) were exposed to various concentrations up to 200 μg/plate of test item in the presence and absence of S9 (Aroclor 1254 induced rat liver homogenate fraction) metabolic activation, by the preincubation method or the plate incorporation method. Under the experimental conditions used, the test item did not induce an increase in the number of revertants in any strain at any dose level, either with or without metabolic activation. Therefore, the test item was not mutagenic.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
See "attached justification". - Reason / purpose for cross-reference:
- read-across source
- Type of assay:
- bacterial reverse mutation assay
- Key result
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- other: no mutagenic potential (based on read-across from analogue substance).
- Conclusions:
- Based on the read-across approach, the test item is not mutagenic.
- Executive summary:
The ability of the analogue substance neohesperidin dihydrochalcone to induce mutation was assessed by the bacterial reverse mutation test (Ames test), performed according to the method described by Ames, similar to OECD 417. Four histidine dependent strains of Salmonella typhimurium (TA1535, TA1537, TA98, TA100) were exposed to various concentrations up to 200 μg/plate of test item in the presence and absence of S9 (Aroclor 1254 induced rat liver homogenate fraction) metabolic activation, by the preincubation method or the plate incorporation method. Under the experimental conditions used, the test item did not induce an increase in the number of revertants in any strain at any dose level, either with or without metabolic activation. Therefore, the analogue substance was not mutagenic. Based on the read-across approach, the test item is not mutagenic.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1977.
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- only 2 strains tested.
- Principles of method if other than guideline:
- Method by Ames (see 'attached background material').
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: donated by Dr. R. Horowitz.
- Name of test material (as cited in study report): neohesperidin dihydrochalcone
- Molecular formula (if other than submission substance): C28H36O15
- Molecular weight (if other than submission substance): 612.5764
- Smiles notation (if other than submission subs.): CC1C(O)C(O)C(O)C(OC2C(O)C(O)C(CO)OC2Oc2cc(O)c(C(=O)CCc3ccc(OC)c(O)c3)c(O)c2)O1
- InChl (if other than submission substance): InChI=1/C28H36O15/c1-11-21(34)23(36)25(38)27(40-11)43-26-24(37)22(35)19(10-29)42-28(26)41-13-8-16(32)20(17(33)9-13)14(30)5-3-12-4-6-18(39-2)15(31)7-12/h4,6-9,11,19,21-29,31-38H,3,5,10H2,1-2H3
- Structural formula attached as image file (if other than submission substance): see Fig. attached. - Target gene:
- Histidine requiring gene of S. typhimurium strains TA98 and TA 100.
- Species / strain / cell type:
- S. typhimurium TA 98
- Additional strain / cell type characteristics:
- not specified
- Species / strain / cell type:
- S. typhimurium TA 100
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9.
- Test concentrations with justification for top dose:
- 40, 120, and 200 mg/plate.
- Vehicle / solvent:
- No data.
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- not specified
- True negative controls:
- not specified
- Positive controls:
- not specified
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: Direct assays of the compounds were conducted at several concentrations, both in the absence and presence of a rat liver microsomal fraction (S9). All determinations were conducted in duplicate.
NUMBER OF REPLICATIONS: 2
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Conclusions:
- The test item was found to be non mutagenic.
- Executive summary:
A study on the mutagenic activity of the test item was performed, following the method of Ames, similar to OECD TG 471. Mutagenic activities of the test substance at up to 200mg/plate were determined directly on Salmonella typhimurium strains TA98 and TA100 (with and without metabolic activation) directly, as well as in a host-mediated assay, and in the urines of rats after oral administration of the test item. In all cases, the test substance was found to be non mutagenic. Therefore, the test item is considered to be non mutagenic under test conditions.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
See "attached justification". - Reason / purpose for cross-reference:
- read-across source
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Histidine requiring gene of S. typhimurium strains TA98 and TA 100.
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Remarks on result:
- other: Read-across from analogue substance.
- Conclusions:
- Based on the read-across approach, the target substance is not mutagenic.
- Executive summary:
A study on the mutagenic activity of the analogue substance neohesperidin dihydrochalcone was performed, following the method of Ames, similar to OECD TG 471. Mutagenic activities of the test substance at up to 200 mg/plate were determined directly on Salmonella typhimurium strains TA98 and TA100 (with and without metabolic activation) directly, as well as in a host-mediated assay, and in the urines of rats after oral administration of the test item. In all cases, the test substance was found to be non mutagenic. Therefore, the analogue substance is considered to be non mutagenic under test conditions. Based on the read-across approach, the target substance is not mutagenic.
Referenceopen allclose all
Table 1. Neohesperidin dihydrochalcone (lab: MIC, solvent: DMSO).
Dose |
TA 100 |
TA 1535 |
||||||||||||||||||
NA (-) |
10% HLI (-) |
30% HLI (-) |
10% RLI (-) |
30% RLI |
NA (-) |
10% HLI (-) |
30% HLI (-) |
10% RLI (-) |
30% RLI |
|||||||||||
μg/plate |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
0.000 |
139 |
9.8 |
71 |
0.9 |
112 |
6.7 |
82 |
3.8 |
100 |
9.0 |
45 |
3.9 |
10 |
1.5 |
14 |
2.4 |
10 |
2.3 |
19 |
1.0 |
100.000 |
136 |
10.8 |
72 |
3.3 |
104 |
2.3 |
75 |
1.9 |
93 |
3.8 |
48 |
7.5 |
10 |
1.8 |
16 |
2.5 |
8 |
1.8 |
13 |
1.2 |
333.000 |
127 |
2.5 |
75 |
3.5 |
95 |
4.8 |
89 |
0.7 |
115 |
11.9 |
33 |
4.4 |
11 |
1.9 |
11 |
3.0 |
12 |
1.7 |
12 |
1.7 |
1000.000 |
128 |
5.2 |
84 |
4.6 |
92 |
8.1 |
84 |
4.5 |
104 |
6.1 |
40 |
4.9 |
11 |
1.2 |
15 |
2.2 |
8 |
3.2 |
15 |
2.7 |
3333.000 |
119 |
2.5 |
74 |
3.7 |
99 |
1.5 |
76 |
6.8 |
99 |
2.0 |
43 |
4.8 |
12 |
1.0 |
10 |
0.9 |
13 |
2.2 |
13 |
2.1 |
10000.000 |
119 |
2.8 |
71 |
2.3 |
106 |
5.9 |
78 |
3.5 |
88 |
1.2 |
41 |
5.9 |
10 |
1.2 |
9 |
1.2 |
11 |
1.0 |
17 |
4.1 |
POS |
1238 |
19.9 |
1232 |
46.7 |
460 |
25.5 |
1077 |
23.8 |
421 |
8.0 |
884 |
33.4 |
149 |
14.5 |
168 |
8.7 |
128 |
10.5 |
106 |
0.6 |
Dose |
TA 97 |
TA 98 |
||||||||||||||||||
NA (-) |
10% HLI (-) |
30% HLI (-) |
10% RLI (-) |
30% RLI |
NA (-) |
10% HLI (-) |
30% HLI (-) |
10% RLI (-) |
30% RLI |
|||||||||||
μg/plate |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
MEAN |
SEM |
0.000 |
96 |
3.7 |
99 |
5.9 |
142 |
6.7 |
101 |
5.8 |
133 |
6.1 |
16 |
3.0 |
34 |
5.8 |
30 |
3.0 |
32 |
2.8 |
44 |
2.7 |
100.000 |
85 |
5.7 |
89 |
0.6 |
124 |
8.8 |
116 |
5.2 |
152 |
6.4 |
18 |
2.2 |
31 |
0.7 |
35 |
0.3 |
32 |
2.3 |
39 |
4.7 |
333.000 |
88 |
7.5 |
85 |
4.1 |
130 |
4.2 |
91 |
8.4 |
138 |
11.9 |
17 |
2.3 |
37 |
2.9 |
30 |
0.6 |
27 |
1.2 |
41 |
0.7 |
1000.000 |
91 |
2.4 |
94 |
5.2 |
125 |
3.1 |
102 |
5.0 |
134 |
9.2 |
20 |
2.3 |
27 |
4.9 |
33 |
5.5 |
26 |
2.7 |
37 |
5.0 |
3333.000 |
82 |
2.0 |
88 |
2.7 |
129 |
3.7 |
110 |
9.4 |
134 |
10.3 |
23 |
1.7 |
30 |
4.1 |
39 |
0.9 |
36 |
1.9 |
41 |
4.1 |
10000.000 |
97 |
4.0 |
88 |
6.0 |
146 |
9.3 |
96 |
4.8 |
147 |
9.2 |
19 |
0.0 |
28 |
2.3 |
34 |
3.3 |
31 |
0.6 |
42 |
2.0 |
POS |
797 |
8.4 |
634 |
17.4 |
378 |
13.0 |
558 |
18.0 |
290 |
12.6 |
1931 |
52.0 |
1212 |
25.4 |
418 |
16.1 |
814 |
37.6 |
366 |
20.2 |
* NA: without metabolic activation, HLI: Aroclor 1254- induced hamster liver homogenate; RLI: Aroclor 1254 -induced rat liver homogenate; (-): negative.
Table 1. Mutagenicity of substituted flavones and related compounds in salmonella typhimurium strain TA98
Test Compound |
nmol/plate |
Mutants/plate |
Control (b) |
|
- S9 |
+ S9 |
|||
35 Hesperetin dihydrochalcone |
50 |
(7) |
6 |
- |
167 |
3 |
(4) |
||
500 |
1 |
(6) |
||
1667 |
(3) |
(8) |
||
36 Neohesperidin dihydrochalcone |
820 |
(3) |
11 |
At 1660 nanomoles/plate, + 10 μg 2-aminofluorene, > 1000 with S-9. |
1640 |
1 |
9 |
||
8197 |
(3) |
18 |
(a) Tabular values are the mean of replicate determination minus the spontaneous control value.
(b) Concurrently determined responses to quercetin (corrected for spontaneous revertants).
Table 1. In vitro mutagenic activities.
Substance |
Amount (mg/plate) |
Number of revertants in excess of controls |
|||
TA 100 |
TA 98 |
||||
- S9 |
+ S9 |
- S9 |
+ S9 |
||
NHDC |
40 |
0 |
0 |
0 |
0 |
120 |
0 |
0 |
0 |
0 |
Table 2. Revertants induced by urines excreted per mouse over 24h after treatment.
Compound and preparation |
Number of revertants in excess of controls |
|||
TA 100 |
TA 98 |
|||
-b-glucuronidase |
+b-glucuronidase |
-b-glucuronidase |
+b-glucuronidase |
|
NHDC |
0 |
0 |
0 |
0 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Genetic toxicity in vitro. Weight of evidence:
- Read-across from supporting substance (structural analogue or surrogate). Source: Key study. Method similar to OECD 471 (no GLP). The analogue substance neohesperidin dihydrochalcone did not induce an increase in the number of revertants in any strain (S. typhimurium TA1535, TA97, TA98, TA100) at any dose level, up to 10000 μg/plate, either with or without metabolic activation [Zeiger, 1987]. Based on the read-across approach, the target substance is not mutagenic.
- Read-across from supporting substance (structural analogue or surrogate). Source: Key study. Method similar to OECD 471 (no GLP). The analogue substance neohesperidin dihydrochalcone up to 8197 μg/plate did not induce an increase in the number of revertants in S. typhimurium TA98 at any dose level [MacGregor, 1978]. Based on the read-across approach, the target substance is not mutagenic.
- Read-across from supporting substance (structural analogue or surrogate). Source: Key study. Method similar to OECD 471 (no GLP). The analogue substance neohesperidin dihydrochalcone up to 200 μg/plate did not induce an increase in the number of revertants in any strain (S. typhimurium TA1535, TA97, TA98, TA100) at any dose level [Brown, 1979]. Based on the read-across approach, the target substance is not mutagenic.
- Read-across from supporting substance (structural analogue or surrogate). Source: Key study. Method of Ames, similar to OECD 471 (no GLP). The analogue substance neohesperidin dihydrochalcone up to 200 mg/plate did not induce an increase in the number of revertants in any strain (S. typhimurium TA98, TA100) at any dose level [Batzinger, 1977]. Based on the read across approach, the target substance is not mutagenic.
Justification for classification or non-classification
Based on the available data (negative results in vitro), it is concluded that the substance is not classified for mutagenicity in accordance with CLP Regulation (EC) No.1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)